Review
Published on 13 Dec 2023
Lipid kinases PIP5Ks and PIP4Ks: potential drug targets for breast cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1323897
- 2,324 views
- 1 citation
Type at least 3 characters
1,825 articles
Articles
Case Report
Published on 07 Dec 2023
Anlotinib combined with radiotherapy and chemotherapy for recurrent pelvic osteosarcoma treatment: a case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1283932
- 1,259 views
- 2 citations
Original Research
Published on 07 Dec 2023
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1184900
- 2,785 views
- 1 citation
Correction
Published on 07 Dec 2023
Corrigendum: Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1334938
- 2,275 views
Original Research
Published on 06 Dec 2023
A tumor cell specific Zona Pellucida glycoprotein 3 RNA transcript encodes an intracellular cancer antigen
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1233039
- 1,537 views
Case Report
Published on 01 Dec 2023
Ribociclib-induced liver injury: a case report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1256783
- 5,713 views
- 4 citations
Systematic Review
Published on 24 Nov 2023
Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1251895
- 4,917 views
- 1 citation
Mini Review
Published on 23 Nov 2023
Repurposing phenothiazines for cancer therapy: compromising membrane integrity in cancer cells
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1320621
- 3,160 views
- 5 citations
Original Research
Published on 20 Nov 2023
A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1049147
- 4,339 views
- 1 citation
Correction
Published on 20 Nov 2023
Corrigendum: Epigenetic-mediated downregulation of zinc finger protein 671 (ZNF671) predicts poor prognosis in multiple solid tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1334056
- 781 views
Review
Published on 16 Nov 2023
Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1239118
- 3,791 views
- 2 citations
Original Research
Published on 14 Nov 2023
The combination of baseline neutrophil to lymphocyte ratio and dynamic changes during treatment can better predict the survival of osteosarcoma patients
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1235158
- 1,336 views
- 2 citations
Original Research
Published on 14 Nov 2023
The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1283951
- 1,937 views
- 1 citation
Retraction
Published on 10 Nov 2023
Retraction: The oncolytic virus in cancer diagnosis and treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1320477
- 2,191 views
Case Report
Published on 09 Nov 2023
Case Report: A novel TP53 mutation in a patient with quadruple wild-type gastrointestinal stromal tumor
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1260706
- 1,370 views
- 1 citation
Mini Review
Published on 08 Nov 2023
Targeting casein kinase 1 for cancer therapy: current strategies and future perspectives
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1244775
- 3,491 views
- 1 citation